Scientific advisory · Lausanne
Where scientific insight meets enterprise decisions.
biodesyn partners with biopharma and biotech teams at the moments that matter: when pipelines need direction, when assets require hard decisions, and when science must translate into outcomes that hold up commercially and operationally.
Three interlocking dimensions
Science
Asset decisions: target selection, protein design, developability, go/no-go advisory. Grounded in molecular-level understanding.
Strategy
Portfolio direction, function-building, cross-functional alignment, and team performance. Translating pipeline progress into organisational outcomes.
Capital allocation
Scientific and commercial narratives for investors and partners. Connecting discovery milestones to the decisions that allocate resources.
Who we support
Biotech & pharma teams
Early discovery through manufacturing readiness for therapeutics and vaccines.
AI-powered startups
Pipeline development, scientific strategy, and biology insights for teams bridging dry-lab and wet-lab.
Funding & partnership teams
Scientific and commercial narratives for investors, grant committees, and strategic partners.
Academic & translational groups
Converting early innovation into viable programs and investment-ready spinouts.